Facebook is cutting down on posts making misleading or exaggerated health claims as part of a drive to improve the quality of information in its news feed.
Digital health firm Livongo has filed to launch on the US stock market, in a bid to raise $100 million and expand its product offering outside the diabetes market where it has its roots.
Imaging company Bracco is to buy Blue Earth Diagnostics for $450 million, netting £337 million for its owner Syncona, the UK’s largest listed life sciences investment firm.
Life sciences venture capitalist Vesalius Biocapital has raised 120 million euros in funding, focusing on investment in digital health as well as biotechs.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.